Back to News
Market Impact: 0.1
Arcutis Biotherapeutics, Inc. Appoints Dr. Robert Scott to Board of Directors
Source: Nasdaq
Management & Governance
On October 23, 2026, Arcutis Biotherapeutics increased its board’s authorized size from 10 to 11 directors and appointed Dr. Robert Scott to the board and its Nominating and Corporate Governance Committee. The report provides no further details on the appointment or its expected impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- FedEx beats expectations, raises outlook in first report since calendar adjustment
- Warsh says politics played no role in Fed’s rate decision by group he is ’honored’ to lead
- Tencent’s Cloud Boss Plays Long Game to Patch ‘Leaky’ AI Ship
- Microsoft reveals strong cloud growth amid financial reporting overhaul
- ECB to hold rates as investors focus on French bonds, Lagarde’s future
- Q2 Holdings reports Q3 revenue of $225.8M, raises guidance